Beranda › Tumor Stromal Gastrointestinal › California
Uji klinis Tumor Stromal Gastrointestinal di California
11 studi untuk Tumor Stromal Gastrointestinal mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Duarte
- GSK Investigational Site, La Jolla
- GSK Investigational Site, Los Angeles
- dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07218926A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
- GSK Investigational Site, San Francisco
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07585266A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06760819DESTINY-PANTUMOUR04
- Research Site, San Diego
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
- USC Norris Comprehensive Cancer Center, Los Angeles
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07406633A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05957367Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
- University of California, San Diego, La Jolla
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT07171203A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- University of California, San Diego, La Jolla
- University of Southern California, Los Angeles
- University Of California, Irvine, Orange
- dan 2 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT06655246A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
- UC San Diego Moores Cancer Center, La Jolla
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT06630234Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- Stanford University School of Medicine, Stanford
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT01048281Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.